These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 19126644)

  • 1. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
    Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR
    Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A direct role of transcription factor E2F in c-myc gene expression during granulocytic and macrophage-like differentiation of HL60 cells.
    Ishida S; Shudo K; Takada S; Koike K
    Cell Growth Differ; 1995 Mar; 6(3):229-37. PubMed ID: 7794791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K; Nakajima Y; Eto K; Ikeda MA
    Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product.
    Luo Q; Li J; Cenkci B; Kretzner L
    Oncogene; 2004 Feb; 23(5):1088-97. PubMed ID: 14716294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
    Polzin RG; Benlhabib H; Trepel J; Herrera JE
    Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three distinct elements within the murine c-myc promoter are required for transcription.
    Moberg KH; Logan TJ; Tyndall WA; Hall DJ
    Oncogene; 1992 Mar; 7(3):411-21. PubMed ID: 1549358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription.
    Cartwright P; Müller H; Wagener C; Holm K; Helin K
    Oncogene; 1998 Aug; 17(5):611-23. PubMed ID: 9704927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
    Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a set of protein species approximately 40 kDa as high-affinity DNA binding factor(s) to the cell cycle regulatory region of the human thymidine kinase promoter.
    Kim EC; Rawlings SL; Li LJ; Roy B; Lee AS
    Cell Growth Differ; 1996 Dec; 7(12):1741-9. PubMed ID: 8959343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription.
    Christensen J; Cloos P; Toftegaard U; Klinkenberg D; Bracken AP; Trinh E; Heeran M; Di Stefano L; Helin K
    Nucleic Acids Res; 2005; 33(17):5458-70. PubMed ID: 16179649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional repression and activation in the same cell type of the human c-MYC promoter by the retinoblastoma gene protein: antagonisation of both effects by SV40 T antigen.
    Batsché E; Lipp M; Cremisi C
    Oncogene; 1994 Aug; 9(8):2235-43. PubMed ID: 8036009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfer of E2F-1 to human glioma cells results in transcriptional up-regulation of Bcl-2.
    Gomez-Manzano C; Mitlianga P; Fueyo J; Lee HY; Hu M; Spurgers KB; Glass TL; Koul D; Liu TJ; McDonnell TJ; Yung WK
    Cancer Res; 2001 Sep; 61(18):6693-7. PubMed ID: 11559537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately.
    Batsché E; Crémisi C
    Oncogene; 1999 Oct; 18(41):5662-71. PubMed ID: 10523846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
    Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
    Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation.
    Yamada M; Kondo T; Ashizawa S; Takebayashi T; Higashi H; Hatakeyama M
    Cytokine; 2002 Jan; 17(2):91-7. PubMed ID: 11886176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different regulation of c-Myc- and E2F-1-induced apoptosis during the ongoing cell cycle.
    Hengstschläger M; Hölzl G; Hengstschläger-Ottnad E
    Oncogene; 1999 Jan; 18(3):843-8. PubMed ID: 9989838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The periodic down regulation of Cyclin E gene expression from exit of mitosis to end of G(1) is controlled by a deacetylase- and E2F-associated bipartite repressor element.
    Polanowska J; Fabbrizio E; Le Cam L; Trouche D; Emiliani S; Herrera R; Sardet C
    Oncogene; 2001 Jul; 20(31):4115-27. PubMed ID: 11464278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAZ induces MYB expression during the exit from quiescence via the E2F site in the MYB promoter.
    Álvaro-Blanco J; Urso K; Chiodo Y; Martín-Cortázar C; Kourani O; Arco PG; Rodríguez-Martínez M; Calonge E; Alcamí J; Redondo JM; Iglesias T; Campanero MR
    Nucleic Acids Res; 2017 Sep; 45(17):9960-9975. PubMed ID: 28973440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast.
    Ben-Yosef T; Yanuka O; Benvenisty N
    Oncogene; 1996 Nov; 13(9):1859-66. PubMed ID: 8934531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.